know
viral
hepat
hepat
mean
inflamm
liver
drug
toxin
heavi
use
alcohol
reduc
blood
suppli
liver
microorgan
includ
virus
may
caus
howev
sign
symptom
hepat
viru
similar
specif
caus
often
undistinguish
without
blood
test
sometim
patient
symptom
patient
experi
symptom
may
includ
jaundic
yellow
eye
skin
fatigu
lethargi
nausea
vomit
loss
appetit
abdomin
pain
fever
sever
case
patient
may
start
notic
swell
feet
abdomen
confus
drowsi
combin
symptom
occur
medic
care
sought
immedi
occur
contagi
viral
hepat
occur
humantohuman
transmiss
though
animaltohuman
transmiss
may
also
occur
differ
virus
may
transmit
either
contamin
water
food
bodili
secret
like
blood
semen
saliva
eg
herpesvirus
droplet
peopl
cough
sneez
influenza
mechan
transmiss
contagi
specif
viru
infect
treat
hepat
caus
virus
usual
treat
symptomat
mean
treat
symptom
liver
inflamm
rather
viru
howev
virus
may
specif
antivir
use
erad
prevent
progress
diseas
know
get
better
recoveri
viral
hepat
typic
start
gradual
resolut
nausea
vomit
abdomin
pain
return
appetit
energi
jaundic
usual
last
resolv
besid
known
hepat
virus
virus
caus
hepat
hepatotrop
virus
common
caus
viral
hepat
worldwid
hepat
b
c
caus
chronic
hepat
howev
nonhepatotrop
virus
caus
acut
hepat
andor
acut
liver
failur
without
caus
chronic
damag
liver
virus
primarili
target
liver
henc
term
nonhepatotrop
use
descript
virus
includ
herpesvirus
epsteinbarr
viru
ebv
cytomegaloviru
cmv
herp
simplex
viru
parvoviru
adenoviru
influenza
sever
acut
respiratori
syndrom
sar
associ
coronaviru
risk
acquir
infect
nonhepatotrop
virus
specif
viru
detail
consider
determin
risk
infect
includ
sanitari
condit
prior
exposur
host
immun
statu
durat
infect
contact
approxim
peopl
worldwid
expos
one
hsv
virus
common
person
usa
seroposit
almost
univers
develop
world
usual
acquir
childhood
secondari
close
contact
infect
famili
member
caus
oral
cold
sore
hand
less
ubiquit
incid
vari
depend
popul
transmiss
almost
exclus
sexual
activ
subgroup
particularli
high
risk
liver
involv
hsv
infect
liver
hsv
uncommon
howev
occur
frequent
lead
acut
liver
failur
high
mortal
sever
hsv
infect
typic
associ
impair
cellmedi
immun
may
occur
transplant
recipi
patient
highdos
steroid
femal
third
trimest
pregnanc
also
particularli
risk
acut
liver
failureth
diagnosi
often
miss
skin
lesion
provid
clinic
clue
diagnosi
often
lack
patient
hsvassoci
hepat
high
degre
suspicion
even
absenc
skin
lesion
combin
earli
diagnost
modal
earli
institut
appropri
therapi
parenter
acyclovir
may
dramat
improv
surviv
four
mechan
hsv
dissemin
result
hepat
hypothes
larg
hsv
inocul
overwhelm
defens
system
b
impair
host
macrophag
cytotox
lymphocyt
delayedtyp
hypersensit
reaction
c
enhanc
virul
activ
latent
hepatovirul
strainhsv
hepat
character
rapid
develop
fulmin
hepat
necrosi
serum
aminotransferas
level
normal
hyperbilirubinemia
posit
serolog
often
point
diagnosi
polymeras
chain
reaction
pcr
confirm
diagnosi
era
widespread
avail
pcr
test
liver
biopsi
less
commonli
need
secur
diagnosi
common
find
liver
biopsi
includ
massiv
liver
necrosi
almost
complet
absenc
portal
tract
central
vein
presenc
typic
intranuclear
viral
inclus
hallmark
find
liver
biopsi
confirm
immunohistochem
staininggiven
timesensit
natur
diseas
initi
empir
therapi
acyclovir
indic
await
diagnost
confirm
patient
acut
liver
failur
varicella
zoster
vzv
caus
chicken
pox
common
albeit
usual
benign
contagi
diseas
spread
easili
infect
peopl
via
direct
contact
droplet
cough
sneez
individu
highest
risk
includ
never
chicken
pox
unimmun
chicken
pox
occur
epidem
among
preschool
schoolag
children
character
gener
vesicular
rash
extrem
prurit
addit
widespread
system
involv
varicella
may
also
caus
rare
congenit
varicella
syndrom
similar
herp
viru
hepat
secondari
varicella
zoster
life
threaten
diseas
sever
pattern
liver
injuri
similar
seen
hsv
hepat
usual
occur
adult
popul
previous
expos
varicella
diagnosi
made
base
serolog
pcr
liver
biopsi
show
diagnost
inclus
immunohistochemistri
treatment
parenter
acyclovir
ebv
one
common
virus
worldwid
usual
asymptomat
though
may
caus
infecti
mononucleosi
im
transmiss
via
saliva
common
among
teen
adult
pattern
liver
injuri
hepatocellular
though
may
rare
cholestat
mark
hyperbilirubinemia
major
patient
develop
hepat
concomit
sign
symptom
im
though
accompani
lymphocytosi
andor
splenomegali
ebv
hepat
affect
older
demograph
compar
im
nearli
half
patient
year
old
usual
selflimit
hepat
improv
support
manag
cmv
usual
spread
infect
saliva
urin
bodi
fluid
healthi
individu
infect
cmv
asymptomat
though
occasion
may
caus
system
diseas
primarili
upper
respiratori
symptom
acquir
vertic
pregnant
woman
fetu
caus
seriou
congenit
diseas
mild
elev
transaminas
almost
alway
present
though
elev
rare
higher
five
time
normal
valu
patient
usual
anicter
improv
support
manag
adenoviru
common
viru
capabl
infect
multipl
organ
system
transmit
via
direct
conjunctiv
inocul
fecalor
rout
aerosol
droplet
exposur
infect
tissu
blood
caus
variou
diseas
syndrom
includ
acut
viral
gastroenter
acut
respiratori
diseas
keratoconjunct
acut
hemorrhag
cystiti
amongst
other
also
caus
adenovir
hepat
lead
sever
fulmin
failur
life
threaten
typic
immunocompromis
transplantrecipi
host
injuri
liver
hepatocellular
transaminas
five
ten
time
upper
limit
normal
serum
level
ast
often
markedli
elev
alt
valu
may
run
sever
thousand
total
bilirubin
ggt
hand
moder
elev
diagnosi
secur
pcr
specif
treatment
though
sever
antivir
includ
ribavirin
ganciclovir
cidofovir
vidarabin
tri
small
popul
modest
success
parvoviru
commonli
infect
children
pregnant
women
spread
primarili
via
respiratori
droplet
though
infect
may
also
occur
via
blood
product
commonli
associ
erythema
infectiosum
otherwis
known
fifth
diseas
childhood
hallmark
fever
rash
classic
known
slappedcheek
appear
mild
upper
respiratori
tract
symptom
begin
approxim
week
exposur
last
day
viru
spread
bone
marrow
enter
erythroid
progenitor
subsequ
caus
lysi
blood
cell
lead
fever
igmmedi
laci
exanthema
adult
commonli
associ
mark
arthropathi
pregnanc
may
caus
aplast
anemia
posttranspl
patient
anoth
atrisk
popul
manifest
refractori
anemia
diagnosi
erythema
infectiosum
clinic
blood
test
indic
confirm
patient
atyp
symptom
adult
typic
enzymelink
immunosorb
assay
elisa
igm
antibodi
andor
pcr
assay
viral
dna
typic
present
serum
month
onset
symptom
present
acut
hepat
fulmin
liver
failur
mostli
report
children
may
also
occur
adult
hepat
cours
less
sever
children
pattern
injuri
typic
hepatocellular
alt
ast
often
three
five
time
normal
valu
preferenti
elev
alanin
transferas
fulmin
hepat
failur
secondari
remain
rare
clinic
entiti
specif
antivir
therapi
vaccin
avail
prevent
influenza
spread
via
respiratori
droplet
human
bird
primari
reservoir
flu
activ
occur
octob
may
usa
occur
yearround
influenza
often
associ
mild
elev
liver
enzym
typic
resolv
clearanc
viru
somewhat
intrigu
viru
typic
infect
respiratori
endotheli
line
hepatocyt
expos
viral
antigen
propos
process
tcell
infiltr
liver
influenza
infect
lead
clinic
signific
hepat
pattern
injuri
typic
hepatocellular
alanin
aminotransferas
alt
aspart
aminotransferas
ast
usual
two
three
time
normal
limit
alkalin
phosphatas
alkp
gammaglutamyl
transpeptidas
ggt
often
normal
anoth
observ
significantli
higher
serum
level
ast
alt
ggt
patient
pandem
influenza
caus
strain
compar
season
influenza
diagnosi
confirm
immunoassay
pcr
hepat
secondari
influenza
rare
progress
acut
liver
failur
occur
process
due
multiorgan
failur
sepsi
ischemia
direct
viral
injuri
treatment
oseltamivir
incid
reduc
outbreak
diminish
sever
due
activ
recruit
care
provid
grassroot
level
encourag
annual
immun
contraind
howev
occasion
viral
mutat
lead
resist
strain
efficaci
vaccin
diminish
sarscov
rel
recent
recogn
viru
first
recogn
perpetr
massiv
outbreak
respiratori
ill
high
mortal
china
virtual
erad
case
report
sinc
though
cdc
declar
select
agent
anoth
viral
outbreak
identifi
merscov
saudi
arabia
bee
report
recent
current
outbreak
merscov
south
korea
sinc
may
sar
mer
covassoci
liver
injuri
report
patient
associ
clinic
signific
hepat
usual
associ
focal
lobular
lymphocyt
infiltr
report
patient
sar
case
although
sarsassoci
coronaviru
detect
liver
tissu
revers
transcriptasepcr
viral
particl
seen
electron
microscopi
specif
therapi
either
virus
variou
antivir
tri
littl
success
apart
interferon
show
modest
improv
symptom
ebola
extrem
contagi
viru
transmit
direct
contact
infect
bodi
fluid
human
primat
primari
reservoir
recent
outbreak
start
march
west
africa
current
ongo
far
result
death
diseas
associ
sever
fulmin
liver
failur
result
massiv
intern
hemorrhag
diagnosi
confirm
igm
elisa
pcr
viru
isol
elev
liver
enzym
hepatocellular
pattern
ast
much
higher
alt
bilirubin
alkp
ggt
modestli
elev
treatment
support
fdaapprov
specif
antivir
therapi
avail
experiment
vaccin
treatment
ebola
develop
yet
fulli
test
safeti
effect
mortal
remain
manag
patient
develop
acut
liver
failur
due
nonhepatotrop
viru
infect
acut
liver
failur
defin
elev
liver
enzym
inr
develop
encephalopathi
someon
without
known
underli
liver
diseas
associ
rapid
progress
high
mortal
first
step
toward
appropri
manag
prompt
transfer
patient
nearest
transplant
center
patient
prefer
admit
critic
care
unit
close
frequent
monitor
sensorium
basic
chemistri
panel
manag
similar
manag
patient
nonacetaminophenassoci
liver
failur
use
nacetylcystein
may
also
role
manag
advanc
encephalopathi
arguabl
challeng
acut
liver
failur
manag
aim
reduc
intracrani
pressur
sedat
indic
propofol
prefer
agent
reduc
brain
edema
earli
transplant
consider
evalu
offer
best
chanc
surviv
patient
acut
liver
failur
even
appropri
manag
mortal
remain
high
prior
transplant
seri
suggest
less
surviv
current
overal
shortterm
surviv
year
includ
undergo
transplant
greater
nonhepatotrop
virus
caus
chronic
diseas
result
elev
risk
liver
cancer
none
nonhepatotrop
virus
possibl
except
shown
caus
chronic
liver
diseas
postul
rare
unusu
etiolog
chronic
hepat
observ
base
identif
viral
dna
hepatocyt
year
origin
infect
howev
extent
result
actual
fibrosi
chronic
damag
unclear
furthermor
interest
focus
possibl
effect
coinfect
natur
histori
chronic
hepat
b
c
similarli
none
virus
associ
liver
cancer
